Safety and potential increased risk of toxicity of radiotherapy combined immunotherapy strategy-Reference-Cited by-同舟云学术

Safety and potential increased risk of toxicity of radiotherapy combined immunotherapy strategy

Published:2022-05-10 Issue:1 Volume:19 Page:35-50
ISSN:1743-7555
Container-title:Asia-Pacific Journal of Clinical Oncology
language:en
Short-container-title:Asia-Pac J Clncl Oncology

Author:

Guan Hui¹,Zhou Ziqi¹^ORCID,Hou Xiaorong¹^ORCID,Zhang Fuquan¹,Zhao Jing²,Hu Ke¹

Affiliation:

1. Department of radiation oncology Peking Union Medical College Hospital Chinese Academy of Medical Sciences and Peking Union Medical College Beijing People's Republic of China

2. Department of Oncology Beijing Shijitan Hospital Capital Medical University Beijing People's Republic of China

Funder

National Natural Science Foundation of China

Publisher

Wiley

Subject

Oncology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/ajco.13688

Reference112 articles.

1. Cancer Immunotherapy by Blocking Immune Checkpoints on Innate Lymphocytes

2. Immune checkpoints in the tumor microenvironment

4. Cemiplimab: A Review in Advanced Cutaneous Squamous Cell Carcinoma

5. The role of radiotherapy in cancer treatment

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Safety and tolerability of radiotherapy in combination with systemic targeted therapies for treatment of hepatocellular carcinoma: a narrative review;Chinese Clinical Oncology;2024-06

2. Exploring Radiation Shielding Efficiency of Eco-Friendly Portland Cement Pastes Made with Barium Sulfate, Silica Fume and Fly Ash;2024

3. Challenges in synergizing radiotherapy with immunotherapy to unlock the abscopal effect in metastatic NSCLC: A systematic review;Neoplasia;2023-09

4. Optimizing the synergy between stereotactic radiosurgery and immunotherapy for brain metastases;Frontiers in Oncology;2023-08-11

5. Overview of the synergistic use of radiotherapy and immunotherapy in cancer treatment: current challenges and scopes of improvement;Expert Review of Anticancer Therapy;2023-02-01